Financial Crime World

Here is the converted article in Markdown format:

Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons Learned

A new study published in the journal Drug Safety highlights the success of Eritrea’s pharmacovigilance system, a crucial component of ensuring patient safety.

Key Strategies and Success Stories

The Eritrean pharmacovigilance system has been successful due to several key strategies, including:

  • Establishing a robust reporting system that allows for prompt identification and investigation of adverse drug reactions (ADRs)
  • Collaboration between healthcare professionals, patients, and regulatory authorities to ensure timely and effective action is taken in response to reported incidents

Some success stories from the Eritrean pharmacovigilance system include:

  • Detecting a previously unknown risk associated with the antimalarial drug artesunate/amodiaquine
  • Successfully managing a cluster of cases of severe hepatotoxicity related to isoniazid preventive therapy among people living with HIV

Challenges and Lessons Learned

Despite these successes, the study also identifies challenges facing the Eritrean pharmacovigilance system, including:

  • Limited resources and infrastructure, which can hinder the timely reporting and investigation of ADRs
  • Need for greater public awareness and education about the importance of reporting suspected ADRs

The authors conclude that lessons learned from Eritrea’s experiences can inform the development of pharmacovigilance systems in other countries, particularly those with limited resources. They emphasize the importance of:

Recommendations

  • Prioritizing the establishment of robust pharmacovigilance systems to ensure patient safety
  • Conducting public awareness and education campaigns to promote the importance of reporting suspected ADRs
  • Fostering collaboration between healthcare professionals, patients, and regulatory authorities for effective management of ADRs

Source

Russom, M., Bahta, I., & Debesai, M. (2021). Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons Learned. Drug Safety, 44(10), 1021-1032. DOI: https://doi.org/10.1007/s40264-021-01102-x